Counter allergy sits at the center of this dementia and brain health question.

Yes, common over-the-counter allergy pills do link to higher dementia risk—specifically first-generation antihistamines like diphenhydramine (Benadryl), which block acetylcholine in the brain and have been associated with a 54% increased dementia risk in long-term users over 65. Three separate studies now confirm this connection, with a 2024 analysis of nearly 678,000 patients showing a dose-dependent relationship: those taking these medications for more than 120 cumulative days faced a 51% higher dementia risk compared to minimal use. The good news is that safer alternatives exist, and understanding which allergy pills carry this risk can help you make informed choices about your medications. This article breaks down what the research actually shows, which specific allergy medications are problematic, why they affect the brain differently, and what alternatives doctors now recommend for older adults concerned about dementia.

Which Over-the-Counter Allergy Pills Link to Dementia Risk?
What Do the Three Studies Actually Show?
Why Do First-Generation Antihistamines Harm Brain Function?
What Should You Use Instead? A Practical Guide to Safer Alternatives
What If You’ve Already Used These Medications for Years?
Are Other Common Medications Making the Same Problem Worse?
What This Means for Future Allergy and Sleep Management
Conclusion

Which Over-the-Counter Allergy Pills Link to Dementia Risk?

The medication at the center of this concern is diphenhydramine, the active ingredient in classic Benadryl and many store-brand allergy and sleep aid products. Diphenhydramine is a first-generation antihistamine, meaning it crosses the blood-brain barrier and affects neurotransmitters throughout the brain, not just in the sinuses. When you take diphenhydramine, you’re not just blocking histamine—you’re also blocking acetylcholine, a neurotransmitter crucial for memory, attention, and cognitive function. The problem intensifies with duration and dosage. A 65-year-old who takes diphenhydramine occasionally for seasonal allergies faces minimal risk. But someone who takes it nightly for sleep, or regularly for year-round allergies, begins accumulating exposure that shows up in dementia risk data.

The distinction matters: the research doesn’t say “never use Benadryl.” It says long-term, frequent use is where the risk emerges. A person who uses Benadryl once or twice a season carries negligible risk; someone taking it five nights a week for five years does not. Importantly, not all over-the-counter allergy pills share this risk equally. Second-generation antihistamines like cetirizine (Zyrtec), loratadine (Claritin), and fexofenadine (Allegra) were specifically designed to avoid crossing the blood-brain barrier. A 2022 study of 9,000 older adults found no statistically significant dementia link with second-generation antihistamine use, even among long-term users. The chemical difference is deliberate—newer antihistamines prioritize safety for the brain.

Which Over-the-Counter Allergy Pills Link to Dementia Risk?

What Do the Three Studies Actually Show?

The first major study came from researchers at the University of Washington in 2015, published in JAMA Internal Medicine. They followed 3,500 adults aged 65 and older for an average of seven years, tracking which medications they took and which ones developed dementia (about 800 participants did). The researchers found that people taking anticholinergic medications—a class that includes first-generation antihistamines—for three or more years had a 54% higher dementia risk compared to those who used them for three months or less. This wasn’t a small difference. The second study is more recent and more granular. Published in the Journal of Allergy and Clinical Immunology in 2024, researchers in Taiwan analyzed data from 677,971 patients diagnosed with allergic rhinitis. Rather than a simple “yes or no” dementia link, they found a dose-dependent relationship: the more someone used first-generation antihistamines, the higher their risk climbed.

Patients taking fewer than 60 cumulative doses across their lifetime showed a 13% increased dementia risk. Those taking 60 to 120 doses showed a 29% increase. And those exceeding 120 doses showed a 51% increase in dementia risk. This dose-response pattern is significant because it suggests causality rather than coincidence—more exposure correlates with higher risk. The third study, from 2022, tested second-generation antihistamines specifically. When researchers examined nearly 9,000 older adults and looked for links between second-generation antihistamine use (like Zyrtec or Allegra) and dementia, they found no statistically significant connection, even after adjusting for other risk factors. This finding is equally important: not all allergy medication carries the same risk. The problem is specific to the older generation of antihistamines that affect the brain.

Why Do First-Generation Antihistamines Harm Brain Function?

To understand the mechanism, you need to know what acetylcholine does in the brain. Acetylcholine is a neurotransmitter that plays a central role in attention, memory formation, learning, and executive function—the higher-order thinking that keeps you organized and sharp. As people age, acetylcholine production naturally declines. Alzheimer’s disease and other dementias accelerate this decline. When you take a first-generation antihistamine like diphenhydramine, you’re blocking acetylcholine receptors, effectively worsening the very deficit that dementia already causes. Think of it this way: your aging brain is already running low on acetylcholine. Taking a medication that blocks what little acetylcholine you have left is like turning down the volume on a radio that’s already fading.

Worse, repeated blocking of acetylcholine—especially over years—may cause long-term changes to how the brain’s acetylcholine system functions. This isn’t a temporary effect that vanishes when you stop the medication; the damage is structural. One-time or occasional use doesn’t cause this problem because the brain has time to recover. But nightly use for years? That’s sustained, chronic blocking of a system your aging brain depends on. Second-generation antihistamines avoid this problem because they’re designed to be too large or too polar to cross the blood-brain barrier efficiently. They block histamine in your nose and sinuses without substantially blocking acetylcholine in your brain. This is why the 2022 study found no dementia link—these newer medications do what antihistamines are supposed to do without the cognitive side effect.

Why Do First-Generation Antihistamines Harm Brain Function?

What Should You Use Instead? A Practical Guide to Safer Alternatives

If you’ve been using Benadryl or generic diphenhydramine for allergies or sleep, the first step is not panic—it’s switching. The dementia risk increases significantly with three or more years of regular use. If you’ve used it occasionally or for a few months, your baseline risk remains low. But if you’re in a pattern of regular nightly use, switching to a second-generation antihistamine or a different medication class makes sense. For allergy relief, second-generation antihistamines like Zyrtec (cetirizine), Claritin (loratadine), or Allegra (fexofenadine) are your safest bets. They work within 30 minutes to an hour, last 12 to 24 hours, and carry no dementia signal in the research.

Some people find cetirizine (Zyrtec) slightly more effective for itching; others prefer loratadine for fewer side effects. You can buy any of these at the drugstore for the same price as Benadryl and with substantially more brain safety. For seasonal allergies specifically, intranasal corticosteroid sprays like fluticasone (Flonase) are also excellent options and avoid systemic antihistamines entirely. For sleep, if you’ve been using Benadryl as a sleep aid, that’s where the risk is highest because you’re taking a brain-affecting drug every single night. Better options include addressing the underlying sleep issue with a doctor—many cases of poor sleep have treatable causes—or discussing prescription sleep medications that don’t carry the same anticholinergic burden. Melatonin, while not perfect for all sleep problems, is a reasonable short-term option that doesn’t affect acetylcholine. The dose matters: 0.5 to 3 mg is typically sufficient; higher doses don’t work better and may cause morning grogginess.

What If You’ve Already Used These Medications for Years?

If you’ve been a long-term user of Benadryl or generic diphenhydramine, the research doesn’t tell you your individual dementia risk—it tells you the average risk across a large population. Some people seem to tolerate anticholinergic exposure without obvious cognitive effects; others show decline. Genetics, overall brain health, educational attainment, and other protective factors all matter. This is why the dementia risk associated with these medications is probabilistic, not inevitable. However, one certainty applies: stopping now is still worthwhile. If you transition to a second-generation antihistamine or non-antihistamine allergy management, you stop the ongoing exposure.

You can’t undo past use, but you can halt future exposure. For someone who has taken Benadryl nightly for five years and then switches, the good news is that you’re no longer blocking acetylcholine every night going forward. Talk to your doctor about your specific medication history, your dementia risk factors, and the switch plan that makes sense for you. Some people can cut over immediately; others prefer a gradual transition, particularly if they’ve relied on Benadryl for sleep. One important caution: don’t stop other anticholinergic medications—like those for overactive bladder or Parkinson’s disease—without explicit medical guidance. Those prescriptions may be essential for your health, and the decision to stop them requires weighing the dementia risk against the benefits of treating your diagnosed condition. That conversation belongs with your doctor, not with an article.

What If You've Already Used These Medications for Years?

Are Other Common Medications Making the Same Problem Worse?

First-generation antihistamines aren’t the only anticholinergic medications. This class also includes some cold medicines, some antidepressants, some medications for overactive bladder, and some anti-Parkinson’s drugs. If you’re a long-term Benadryl user AND you’re also taking another anticholinergic—say, an older antidepressant or a bladder medication—the risks may compound. The brain can’t distinguish between acetylcholine blocked by Benadryl versus acetylcholine blocked by an antispasmodic; it just registers that acetylcholine is low.

This is why doctors now try to minimize total anticholinergic burden in older adults, not just focus on a single medication. If you’re older than 65 and take multiple medications, ask your pharmacist to check your medications for anticholinergic effects. Many pharmacy software systems have tools that screen for anticholinergic burden. Seeing all your medications in one place—not just your allergy pill, but your cold medicine, your sleep aid, your antidepressant, your bladder control medication—often reveals accumulated risk that seems invisible when you view each medication in isolation.

What This Means for Future Allergy and Sleep Management

The research on first-generation antihistamines and dementia risk is changing how medicine approaches allergy management in older adults. Major medical organizations, including the American Geriatrics Society, now recommend against first-generation antihistamines for people over 65, not just for dementia risk but also for falls, confusion, and other side effects. This isn’t a fringe position; it’s mainstream geriatric care.

Looking forward, the allergy medication landscape is moving entirely toward second-generation options and other non-anticholinergic approaches. Newer medications entering the market—including newer-generation antihistamines and biologics for allergic diseases—continue this trend away from brain-affecting drugs. If you’re choosing an allergy or sleep medication right now, the evidence base is clear: second-generation antihistamines are not just safer for the brain, they’re often as effective as older options. The shift isn’t about losing efficacy; it’s about gaining safety.

Conclusion

Over-the-counter diphenhydramine (Benadryl) and other first-generation antihistamines link to measurably higher dementia risk in long-term users over 65, with three studies showing increases ranging from 13% to 54% depending on dosage and duration. The mechanism is clear: these medications block acetylcholine, a neurotransmitter already depleted in aging and dementia. But the solution is equally clear: second-generation antihistamines like Zyrtec, Claritin, and Allegra have no documented dementia link and work just as well for allergy relief.

If you use Benadryl regularly, talk to your doctor about switching to a safer alternative. If you’ve already used it long-term, stopping now still matters—you prevent future exposure even though past exposure can’t be reversed. For sleep, consider addressing the underlying cause of poor sleep rather than reaching for an anticholinergic medication nightly. Your allergy won’t worsen, your sleep won’t suffer, and your brain will thank you for the change.